Tower Research Capital LLC (Trc) Revelation Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$0.18 - $431.55 $56 - $134,643
-312 Reduced 3.55%
8,472 $2,000
Q3 2022

Nov 10, 2022
BUY
$0.09 - $1438.5 $265 - $4.25 Million
2,954 Added 50.67%
8,784 $2,000
Q2 2022

Aug 15, 2022
BUY
$448.98 - $1344.0 $1.05 Million - $3.13 Million
2,328 Added 66.48%
5,830 $6,000
Q1 2022

May 12, 2022
BUY
$971.04 - $11077.5 $3.4 Million - $38.8 Million
3,502 New
3,502 $4,000

Others Institutions Holding REVB

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About REVELATION BIOSCIENCES, INC.

REVB Quotes by TradingView
  • Ticker REVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,525,800
  • Market Cap $20M
  • Description
  • Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal conge...
More about REVB
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email